Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash Flows From Operating Activities | ||
| Net loss | $(1,431) | $(86) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization of intangible assets | 295 | 305 |
| Amortization and write-off of debt premiums, discounts and issuance costs | 14 | 15 |
| Goodwill impairments | 1,426 | — |
| Acquisition-related contingent consideration | 12 | (11) |
| Allowances for losses on trade receivable and inventories | 26 | 26 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's D&A?
- Bausch Health Companies (BHC) reported D&A of $295M in Q1 2026.
- How has Bausch Health Companies's D&A changed year-over-year?
- Bausch Health Companies's D&A decreased by 3.3% year-over-year, from $305M to $295M.
- What is the long-term trend for Bausch Health Companies's D&A?
- Over 4 years (2021 to 2025), Bausch Health Companies's D&A has grown at a -6.1% compound annual growth rate (CAGR), from $1.55B to $1.21B.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Bausch Health Companies's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude